NUVL Nuvalent
- 73.010
- +2.360+3.34%
Nuvalent News
Nuvalent(NUVL.US) Director Sells US$2.67 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 39,500 shares of common stock on Apr 29, 2024 at an average price of $67.51 for a total value of $2.67 million.Source: Announcement What is statement of
Nuvalent Insider Sold Shares Worth $2,666,555, According to a Recent SEC Filing
Matthew Shair, Director, on April 29, 2024, sold 39,500 shares in Nuvalent (NUVL) for $2,666,555. Following the Form 4 filing with the SEC, Shair has control over a total of 1,736,220 shares of the co
Nuvalent(NUVL.US) Director Sells US$2.39 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 22, 2024 at an average price of $63.65 for a total value of $2.39 million.Source: Announcement What is statement of
We're Not Very Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
Jefferies Starts Nuvalent at Buy, Cites Lung Cancer Drug Candidates
Nuvalent(NUVL.US) Director Sells US$2.46 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 15, 2024 at an average price of $65.56 for a total value of $2.46 million.Source: Announcement What is statement of
Nuvalent(NUVL.US) Director Sells US$327.61K in Common Stock
$Nuvalent(NUVL.US)$ Director Conley Emily sold 5,000 shares of common stock on Apr 15, 2024 at an average price of $65.52 for a total value of $327.61K.Source: Announcement What is statement of change
Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing
Matthew Shair, Director, on April 15, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,458,335. Following the Form 4 filing with the SEC, Shair has control over a total of 1,813,220 shares of the co
Nuvalent Initiated at Buy by Jefferies
Nuvalent Initiated at Buy by Jefferies
Express News | Nuvalent Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $97
Nuvalent(NUVL.US) Director Sells US$2.57 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 8, 2024 at an average price of $68.44 for a total value of $2.57 million.Source: Announcement What is statement of
Nuvalent Insider Sold Shares Worth $2,566,479, According to a Recent SEC Filing
Matthew Shair, Director, on April 08, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,566,479. Following the Form 4 filing with the SEC, Shair has control over a total of 1,850,720 shares of the co
Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024
Preclinical data continue to support NVL-330's broad activity against HER2 oncogenic alterations, selectivity over wild-type EGFR, and differentiated brain-penetrant profile .
Express News | Nuvalent Presents New Preclinical Data For HER2-Selective Inhibitor, NVL-330, And ROS1-Selective Inhibitor, Zidesamtinib, At AACR Annual Meeting 2024
Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors -- Barrons.com
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen
Nuvalent(NUVL.US) Officer Sells US$220.79K in Common Stock
$Nuvalent(NUVL.US)$ Officer Miller Deborah Ann sold 3,000 shares of Common Stock on Apr 4, 2024 at an average price of $73.6 for a total value of $220.79K.Source: Announcement What is statement of cha
Nuvalent(NUVL.US) Director Sells US$2.88 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of Common Stock on Apr 1, 2024 at an average price of $76.92 for a total value of $2.88 million.Source: Announcement What is statement of
Nuvalent Raised to Outperform From Market Perform by Leerink Partners
Nuvalent Raised to Outperform From Market Perform by Leerink Partners
Nuvalent Insider Sold Shares Worth $1,654,311, According to a Recent SEC Filing
Deborah Ann Miller, Chief Legal Officer, on March 28, 2024, sold 22,000 shares in Nuvalent (NUVL) for $1,654,311. Following the Form 4 filing with the SEC, Miller has control over a total of 33,300 sh
Analysis
Price Target
No Data
